As of Jan 13
| +1.97 / +3.68%|
The 9 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 49.00, with a high estimate of 55.00 and a low estimate of 36.00. The median estimate represents a -11.65% decrease from the last price of 55.46.
The current consensus among 9 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.